Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nesthus

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 1, 2000
[High dose chemotherapy with autologous stem cell support in cancer patients]J F Abrahamsen, E K Kristoffersen, T Hervig, et al.
The Journal of Clinical Investigation|November 1, 1996
Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine StudyA B Guttormsen, P M Ueland, I Nesthus, et al.
European Journal of Haematology|August 1, 1997
Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995J M Tangen, M Abdelnoor, L Brinch, et al.
Leukemia|November 1, 1995
Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemiaO Bruserud, B Tore Gjertsen, O T Brustugun, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 18, 2001
[High dose therapy with autologous stem cell support--finally a progress in myelomatosis]F Wisløff, J M Tangen, L Brinch, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 1999
[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96]J Lamvik, L Brinch, I M Dahl, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Blood|December 23, 1999
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study GroupS Lenhoff, M Hjorth, E Holmberg, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 1, 2000
[High dose chemotherapy with autologous stem cell support in cancer patients]J F Abrahamsen, E K Kristoffersen, T Hervig, et al.
The Journal of Clinical Investigation|November 1, 1996
Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine StudyA B Guttormsen, P M Ueland, I Nesthus, et al.
European Journal of Haematology|August 1, 1997
Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995J M Tangen, M Abdelnoor, L Brinch, et al.
Leukemia|November 1, 1995
Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemiaO Bruserud, B Tore Gjertsen, O T Brustugun, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 18, 2001
[High dose therapy with autologous stem cell support--finally a progress in myelomatosis]F Wisløff, J M Tangen, L Brinch, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 1999
[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96]J Lamvik, L Brinch, I M Dahl, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Blood|December 23, 1999
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study GroupS Lenhoff, M Hjorth, E Holmberg, et al.
Pageof 3